Have your say: A Clinician’s Perspective on the Role of Gastric Cancer Patient-Derived Organoids in Precision Medicine
We’re inviting clinicians to take part in a short 5-minute survey and share their insights on the use of patient-derived organoids to personalise chemotherapy for patients with non-curative gastric adenocarcinoma. Your insights will help guide future research and assess how this emerging technology could be integrated into clinical practice.
Open to oncologists, surgeons, gastroenterologists, radiation oncologists, trainees, and other cancer care professionals
Optional: Add your name/email to be acknowledged as part of the Gastric Cancer Organoid Survey Group and receive authorship on resulting publications
Click here to take the survey: https://redcap.link/GastricCancerOrganoidSurvey
Gallery
Related Articles
Research Invitation: Feasibility Study for a New Functional Dyspepsia Wellbeing App
This study aims to evaluate the acceptability and feasibility of this digital delivery method.
Member Research Update
NZSG Member Dr Stephanie Brown combines clinical practice with a clinically embedded research programme focused on impro...
Reviewers Needed
Dr Sally Rye, Head of Research at EIT, research project Puka Ora is looking for clinicians with gut health experience.